SLC12A5
Basic information
Region (hg38): 20:46021690-46060150
Links
Phenotypes
GenCC
Source:
- malignant migrating partial seizures of infancy (Supportive), mode of inheritance: AD
- developmental and epileptic encephalopathy, 34 (Strong), mode of inheritance: AR
- developmental and epileptic encephalopathy, 34 (Moderate), mode of inheritance: AR
- epilepsy, idiopathic generalized, susceptibility to, 14 (No Known Disease Relationship), mode of inheritance: AD
- epilepsy, idiopathic generalized, susceptibility to, 14 (Limited), mode of inheritance: AD
- developmental and epileptic encephalopathy, 34 (Limited), mode of inheritance: AR
- developmental and epileptic encephalopathy (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Developmental and epileptic encephalopathy 34 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 26333769 |
ClinVar
This is a list of variants' phenotypes submitted to
- Developmental and epileptic encephalopathy, 34 (24 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC12A5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 247 | 14 | 268 | |||
missense | 298 | 309 | ||||
nonsense | 10 | |||||
start loss | 0 | |||||
frameshift | 15 | 15 | ||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
splice region | 23 | 41 | 1 | 65 | ||
non coding | 129 | 16 | 148 | |||
Total | 24 | 12 | 310 | 382 | 31 |
Highest pathogenic variant AF is 0.00000658
Variants in SLC12A5
This is a list of pathogenic ClinVar variants found in the SLC12A5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-46021770-G-A | Developmental and epileptic encephalopathy, 34;Epilepsy, idiopathic generalized, susceptibility to, 14 | Uncertain significance (Jun 26, 2020) | ||
20-46021773-G-A | not specified | Uncertain significance (Dec 04, 2020) | ||
20-46021797-C-G | Uncertain significance (Jan 01, 2022) | |||
20-46021799-C-G | Uncertain significance (Jan 01, 2024) | |||
20-46021836-G-A | Uncertain significance (Sep 01, 2019) | |||
20-46021839-G-A | not specified | Uncertain significance (Apr 26, 2022) | ||
20-46021840-G-A | Likely benign (May 01, 2024) | |||
20-46021868-C-A | SLC12A5-related disorder | Uncertain significance (Jun 21, 2024) | ||
20-46021872-G-A | Uncertain significance (Jul 01, 2023) | |||
20-46021881-T-A | Developmental and epileptic encephalopathy, 34 | Uncertain significance (Nov 10, 2023) | ||
20-46021890-G-C | not specified | Uncertain significance (May 04, 2022) | ||
20-46021894-C-A | Likely benign (May 01, 2022) | |||
20-46022179-A-G | Benign (Nov 12, 2018) | |||
20-46022943-G-GGGAGGAGGAGGAGGA | Likely benign (Mar 01, 2023) | |||
20-46022965-GGAGGAGGAGGAAGAGGAGGAGGAGGAA-G | not specified | Benign (May 04, 2022) | ||
20-46022971-GGAGGAAGAGGAGGAGGAGGAA-G | not specified | Benign (May 04, 2022) | ||
20-46022977-A-G | not specified | Benign/Likely benign (May 04, 2022) | ||
20-46022977-A-AGGAG | not specified | Benign (May 04, 2022) | ||
20-46023148-C-T | not specified | Benign (Jul 15, 2024) | ||
20-46029350-A-G | Developmental and epileptic encephalopathy, 34 | Likely benign (Aug 21, 2022) | ||
20-46029353-C-T | Developmental and epileptic encephalopathy, 34 | Likely benign (Aug 17, 2023) | ||
20-46029361-C-T | Developmental and epileptic encephalopathy, 34 | Uncertain significance (Aug 04, 2023) | ||
20-46029362-G-A | Developmental and epileptic encephalopathy, 34 | Likely benign (Feb 24, 2023) | ||
20-46029365-C-A | Developmental and epileptic encephalopathy, 34 | Uncertain significance (Aug 24, 2021) | ||
20-46029368-C-A | Developmental and epileptic encephalopathy, 34 | Pathogenic (Oct 17, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC12A5 | protein_coding | protein_coding | ENST00000454036 | 26 | 38429 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 1.81e-7 | 125742 | 0 | 5 | 125747 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.70 | 347 | 696 | 0.498 | 0.0000404 | 7435 |
Missense in Polyphen | 63 | 256.45 | 0.24566 | 2697 | ||
Synonymous | 1.01 | 253 | 274 | 0.922 | 0.0000161 | 2301 |
Loss of Function | 6.58 | 3 | 56.3 | 0.0533 | 0.00000295 | 621 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000183 | 0.0000176 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Mediates electroneutral potassium-chloride cotransport in mature neurons and is required for neuronal Cl(-) homeostasis. As major extruder of intracellular chloride, it establishes the low neuronal Cl(-) levels required for chloride influx after binding of GABA-A and glycine to their receptors, with subsequent hyperpolarization and neuronal inhibition (By similarity). Involved in the regulation of dendritic spine formation and maturation (PubMed:24668262). {ECO:0000250|UniProtKB:Q63633, ECO:0000269|PubMed:24668262}.;
- Disease
- DISEASE: Epilepsy, idiopathic generalized 14 (EIG14) [MIM:616685]: An autosomal dominant form of idiopathic generalized epilepsy, a disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. Seizure types include juvenile myoclonic seizures, absence seizures, and generalized tonic-clonic seizures. {ECO:0000269|PubMed:24668262, ECO:0000269|PubMed:24928908, ECO:0000269|PubMed:26528127}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- GABAergic synapse - Homo sapiens (human);Cation-coupled Chloride cotransporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules
(Consensus)
Recessive Scores
- pRec
- 0.153
Intolerance Scores
- loftool
- 0.00861
- rvis_EVS
- -1.37
- rvis_percentile_EVS
- 4.45
Haploinsufficiency Scores
- pHI
- 0.613
- hipred
- Y
- hipred_score
- 0.809
- ghis
- 0.628
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.366
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc12a5
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- slc12a5b
- Affected structure
- retinal ganglion cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased functionality
Gene ontology
- Biological process
- ion transport;cellular ion homeostasis;cell volume homeostasis;hypotonic response;chemical synaptic transmission;learning;cellular chloride ion homeostasis;multicellular organism growth;thermosensory behavior;response to drug;chloride ion homeostasis;potassium ion homeostasis;dendritic spine development;chloride transmembrane transport;potassium ion import across plasma membrane
- Cellular component
- plasma membrane;integral component of plasma membrane;integral component of membrane
- Molecular function
- chloride transmembrane transporter activity;potassium:chloride symporter activity